Skip to main content

Advertisement

Log in

Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study

  • Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

The clinical significance of metabolic syndrome (MetS) versus its single components in erectile dysfunction (ED) is conflicting. Thus, the purpose is to analyze the available evidence on the relationship between MetS—along with its components—and ED.

Methods

All prospective and retrospective observational studies reporting information on ED and MetS were included. In addition, we here reanalyzed preclinical and clinical data obtained from a previously published animal model of MetS and from a consecutive series of more than 2697 men (mean age: 52.7 ± 12), respectively.

Results

Data derived from this meta-analysis showed that MetS was associated with an up to fourfold increased risk of ED when either unadjusted or adjusted data were considered. Meta-regression analysis, performed using unadjusted statistics, showed that the MetS-related risk of ED was closely associated with all the MetS components. These associations were confirmed when unadjusted analyses from clinical models were considered. However, fully adjusted data showed that MetS-associated ED was more often due to morbidities included (or not) in the algorithm than to the MetS diagnostic category itself. MetS is also associated with low testosterone, but its contribution to MetS-associated ED—as derived from preclinical and clinical models—although independent, is marginal.

Conclusions

The results of our analysis suggest that MetS is a useless diagnostic category for studying ED. However, treating the individual MetS components is important, because they play a pivotal role in determining ED.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Lotti F, Marchiani S, Corona G, Maggi M (2021) Metabolic syndrome and reproduction. Int J Mol Sci 22(4):1988. https://doi.org/10.3390/ijms22041988

  2. Esposito K, Giugliano F, Martedì E, Feola G, Marfella R, D’Armiento M et al (2005) High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 28(5):1201–1203

    Article  PubMed  Google Scholar 

  3. Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al (2006) Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 50(3):595–604 (discussion)

  4. Demir T, Demir O, Kefi A, Comlekci A, Yesil S, Esen A (2006) Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 13(4):385–388

    Article  PubMed  Google Scholar 

  5. Liu LH, Zhang T, Zhang YR, Liu TS, Zhang HB, Chen FZ et al (2014) Metabolic syndrome and risk for ED: a meta-analysis. Int J Impot Res 26(5):196–200

    Article  CAS  PubMed  Google Scholar 

  6. Besiroglu H, Otunctemur A, Ozbek E (2015) The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med 12(6):1309–1318

    Article  CAS  PubMed  Google Scholar 

  7. Corona G, Rastrelli G, Isidori AM, Pivonello R, Bettocchi C, Reisman Y et al (2020) Erectile dysfunction and cardiovascular risk: a review of current findings. Expert Rev Cardiovasc Ther 18(3):155–164

    Article  CAS  PubMed  Google Scholar 

  8. Antonio L, Wu FCW, Moors H, Matheï C, Huhtaniemi IT, Rastrelli G et al (2022) Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status. Age Ageing 51(4):afac094. https://doi.org/10.1093/ageing/afac094

  9. Corona G, Rastrelli G, Balercia G, Lotti F, Sforza A, Monami M et al (2012) Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. J Sex Med 9(6):1669–1680

    Article  CAS  PubMed  Google Scholar 

  10. Corona G, Monami M, Rastrelli G, Melani C, Balzi D, Sforza A et al (2011) Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction. J Sex Med 8(2):504–511

    Article  PubMed  Google Scholar 

  11. Corona G, Maggi M (2022) The role of testosterone in male sexual function. Rev Endocr Metab Disord 23(6):1159–1172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Corona G, Rastrelli G, Vignozzi L, Maggi M (2022) Androgens and male sexual function. Best Pract Res Clin Endocrinol Metab 36(4):101615. https://doi.org/10.1016/j.beem.2022.101615

    Article  CAS  PubMed  Google Scholar 

  13. Corona G, Torres LO, Maggi M (2020) Testosterone therapy: what we have learned from trials. J Sex Med 17(3):447–460

    Article  CAS  PubMed  Google Scholar 

  14. Rastrelli G, Corona G, Maggi M (2018) Testosterone and sexual function in men. Maturitas 112:46–52

    Article  CAS  PubMed  Google Scholar 

  15. Rastrelli G, Guaraldi F, Reismann Y, Sforza A, Isidori AM, Maggi M et al (2019) Testosterone replacement therapy for sexual symptoms. Sex Med Rev. 7(3):464–475

    Article  PubMed  Google Scholar 

  16. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F et al (2011) Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 8(1):272–283

    Article  CAS  PubMed  Google Scholar 

  17. Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B et al (2009) Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med 6(12):3274–3288

    Article  CAS  PubMed  Google Scholar 

  18. Morelli A, Filippi S, Comeglio P, Sarchielli E, Cellai I, Pallecchi M et al (2019) Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. Am J Physiol Endocrinol Metab 316(3):E519–E535

    Article  CAS  PubMed  Google Scholar 

  19. Marchiani S, Vignozzi L, Filippi S, Gurrieri B, Comeglio P, Morelli A et al (2015) Metabolic syndrome-associated sperm alterations in an experimental rabbit model: relation with metabolic profile, testis and epididymis gene expression and effect of tamoxifen treatment. Mol Cell Endocrinol 401:12–24

    Article  CAS  PubMed  Google Scholar 

  20. Morelli A, Sarchielli E, Comeglio P, Filippi S, Vignozzi L, Marini M et al (2014) Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Mol Cell Endocrinol 382(1):107–119

    Article  CAS  PubMed  Google Scholar 

  21. Corona G, Mannucci E, Petrone L, Fisher AD, Balercia G, De Scisciolo G et al (2006) Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. J Androl 27(3):453–458

    Article  PubMed  Google Scholar 

  22. Corona G, Ricca V, Bandini E, Mannucci E, Petrone L, Fisher AD et al (2008) Association between psychiatric symptoms and erectile dysfunction. J Sex Med 5(2):458–468

    Article  PubMed  Google Scholar 

  23. Bal K, Oder M, Sahin AS, Karataş CT, Demir O, Can E et al (2007) Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 69(2):356–360

    Article  PubMed  Google Scholar 

  24. Yeh HC, Wang CJ, Lee YC, Hsiao HL, Wu WJ, Chou YH et al (2008) Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. Kaohsiung J Med Sci 24(5):240–247

    Article  CAS  PubMed  Google Scholar 

  25. Demir O, Demir T, Kefi A, Secil M, Comlekci A, Yesil S et al (2009) Penile vascular impairment in erectile dysfunction patients with metabolic syndrome: penile Doppler ultrasound findings. Urol Int 82(2):175–178

    Article  CAS  PubMed  Google Scholar 

  26. Gatti A, Mandosi E, Fallarino M, Radicioni A, Morini E, Maiani F et al (2009) Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects. J Endocrinol Investig 32(6):542–545

    Article  CAS  Google Scholar 

  27. Koca O, Calışkan S, Oztürk M, Güneş M, Kılıçoğlu G, Karaman MI (2010) Vasculogenic erectile dysfunction and metabolic syndrome. J Sex Med 7(12):3997–4002

    Article  PubMed  Google Scholar 

  28. Lee YC, Liu CC, Huang CN, Li WM, Wu WJ, Yeh HC et al (2010) The potential impact of metabolic syndrome on erectile dysfunction in aging Taiwanese males. J Sex Med 7(9):3127–3134

    Article  PubMed  Google Scholar 

  29. Aktas BK, Gokkaya CS, Bulut S, Dinek M, Ozden C, Memis A (2011) Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male 14(1):48–52

    Article  PubMed  Google Scholar 

  30. Pohjantähti-Maaroos H, Palomäki A (2011) Comparison of metabolic syndrome subjects with and without erectile dysfunction—levels of circulating oxidised LDL and arterial elasticity. Int J Clin Pract 65(3):274–280

    Article  PubMed  Google Scholar 

  31. Tan WS, Ng CJ, Khoo EM, Low WY, Tan HM (2011) The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study). Aging Male 14(4):231–236

    Article  CAS  PubMed  Google Scholar 

  32. Chao JK, Kuo WH, Chiang HS, Hwang TI, Chao IC, Chiang SK (2012) Association of metabolic syndrome, atherosclerosis risk factors, sex hormones in ED in aboriginal Taiwanese. Int J Impot Res 24(4):141–146

  33. Chen K, Mi H, Gao Y, Tan A, Lu Z, Wu C et al (2012) Metabolic syndrome: a potential and independent risk factor for erectile dysfunction in the Chinese male population. Urology 80(6):1287–1292

    Article  PubMed  Google Scholar 

  34. García-Cruz E, Leibar-Tamayo A, Romero J, Piqueras M, Luque P, Cardeñosa O et al (2013) Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med 10(10):2529–2538

    Article  PubMed  Google Scholar 

  35. Weinberg AE, Eisenberg M, Patel CJ, Chertow GM, Leppert JT (2013) Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction. J Sex Med 10(12):3102–3109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Aslan Y, Guzel O, Balci M, Tuncel A, Yildiz M, Atan A (2014) The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. Aging Male 17(2):76–80

    Article  CAS  PubMed  Google Scholar 

  37. Gorgel SN, Gorgel A, Sefik E (2014) Sexual function in male patients with metabolic syndrome and effective parameters on erectile dysfunction. Int Braz J Urol 40(1):56–61

    Article  PubMed  Google Scholar 

  38. Park JH, Cho IC, Kim YS, Kim SK, Min SK, Kye SS (2015) Body mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men’s health. Korean J Urol 56(5):386–392

    Article  PubMed  PubMed Central  Google Scholar 

  39. Chaudhary RK, Shamsi BH, Tan T, Chen HM, Xing JP (2016) Study of the relationship between male erectile dysfunction and type 2 diabetes mellitus/metabolic syndrome and its components. J Int Med Res 44(3):735–741

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. De Nunzio C, Lombardo R, Gacci M, Nacchia A, Presicce F, Alkhatatbeh H et al (2017) Metabolic syndrome does not increase the risk of ejaculatory dysfunction in patients with lower urinary tract symptoms and benign prostatic enlargement: an Italian single-center cohort study. Urology 105:85–90

    Article  PubMed  Google Scholar 

  41. Erkoc M, Besiroglu H, Otunctemur A, Polat EC, Bozkurt M (2020) Metabolic syndrome is associated worsened erectile function in patients undergoing TURP due to benign prostatic hyperplasia. Aging Male 23(5):533–537

    Article  PubMed  Google Scholar 

  42. Salama MN, Eid AA, Hatem A, Swidan AK (2020) Prevalence of erectile dysfunction in Egyptian males with metabolic syndrome. Aging Male 23(4):257–263

    Article  PubMed  Google Scholar 

  43. Bolat MS, Ozbek ML, Şahin B, Yılmaz M, Kocamanoglu F, Buyukalpelli R et al (2021) Impact of high visceral adiposity index associated with metabolic syndrome on erectile function in sexually active men: results of a cross-sectional study. Int J Clin Pract 75(6):e14111

    Article  CAS  PubMed  Google Scholar 

  44. Neuzillet Y, Dreyfus JF, Raynaud JP, Rouanne M, Schneider M, Roupret M et al (2021) Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy. Asian J Androl 23(5):520–526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60(5):1010–1016

    Article  PubMed  Google Scholar 

  46. Corona G, Rastrelli G, Vignozzi L, Barbonetti A, Sforza A, Mannucci E et al (2021) The role of testosterone treatment in patients with metabolic disorders. Expert Rev Clin Pharmacol 14(9):1091–1103. https://doi.org/10.1080/17512433.2021.1938548

    Article  CAS  PubMed  Google Scholar 

  47. Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G et al (2020) European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: endorsing organization: European Society of Endocrinology. Andrology 8(5):970–987

    Article  PubMed  Google Scholar 

  48. Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC et al (2021) European Association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol 80(3):333–357

    Article  PubMed  Google Scholar 

  49. Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F et al (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(12):2385–2403. https://doi.org/10.1007/s40618-022-01859-

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S (2016) Animal models of metabolic syndrome: a review. Nutr Metab (Lond) 13:65

    Article  PubMed  Google Scholar 

  51. Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y et al (2022) Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786. https://doi.org/10.3390/ijms23020786

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Pitsavos C, Panagiotakos D, Weinem M, Stefanadis C (2006) Diet, exercise and the metabolic syndrome. Rev Diabet Stud 3(3):118–126

    Article  PubMed  PubMed Central  Google Scholar 

  53. Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Marchetta M et al (2014) Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. J Sex Med 11(12):2890–2902

    Article  CAS  PubMed  Google Scholar 

  54. Maggi R, Zasso J, Conti L (2014) Neurodevelopmental origin and adult neurogenesis of the neuroendocrine hypothalamus. Front Cell Neurosci 8:440

    PubMed  Google Scholar 

  55. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752

    Article  PubMed  Google Scholar 

  56. Rastrelli G, Filippi S, Sforza A, Maggi M, Corona G (2018) Metabolic syndrome in male hypogonadism. Front Horm Res 49:131–155

    Article  CAS  PubMed  Google Scholar 

  57. Von Korff M, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data. J Clin Epidemiol 45(2):197–203

    Article  Google Scholar 

  58. Rastrelli G, Corona G, Maggi M (2020) Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction. Asian J Androl 22(3):265–273

    Article  CAS  PubMed  Google Scholar 

  59. Brand JS, Rovers MM, Yeap BB, Schneider HJ, Tuomainen TP, Haring R et al (2014) Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS ONE 9(7):e100409

    Article  PubMed  PubMed Central  Google Scholar 

  60. Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R et al (2003) Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res 15(3):210–220

    Article  CAS  PubMed  Google Scholar 

  61. Corona G, Sansone A, Pallotti F, Ferlin A, Pivonello R, Isidori AM et al (2020) People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction. J Endocrinol Investig 43(10):1391–1408

    Article  CAS  Google Scholar 

  62. Marieke D, Joana C, Giovanni C, Erika L, Patricia P, Yacov R et al (2020) Sexual desire discrepancy: a position statement of the european society for sexual medicine. Sex Med 8(2):121–131

    Article  PubMed  PubMed Central  Google Scholar 

  63. Dewitte M, Bettocchi C, Carvalho J, Corona G, Flink I, Limoncin E et al (2021) A psychosocial approach to erectile dysfunction: position statements from the European Society of Sexual Medicine (ESSM). Sex Med 9(6):100434

    Article  PubMed  PubMed Central  Google Scholar 

  64. Boddi V, Corona G, Fisher AD, Mannucci E, Ricca V, Sforza A et al (2012) “It takes two to tango”: the relational domain in a cohort of subjects with erectile dysfunction (ED). J Sex Med 9(12):3126–3136

    Article  PubMed  Google Scholar 

  65. Corona G, Ricca V, Bandini E, Rastrelli G, Casale H, Jannini EA et al (2012) SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. J Sex Med 9(8):2017–2026

    Article  PubMed  Google Scholar 

  66. Grossmann M, Mg Tang Fui M, Cheung AS (2020) Late-onset hypogonadism: metabolic impact. Andrology 8(6):1519–1529

    Article  CAS  PubMed  Google Scholar 

  67. Corona G, Isidori AM, Aversa A, Burnett AL, Maggi M (2016) Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med 13(3):317–337

    Article  PubMed  Google Scholar 

  68. Corona G, Rastrelli G, Ricca V, Jannini EA, Vignozzi L, Monami M et al (2013) Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction. J Sex Med 10(4):1074–1089

    Article  PubMed  Google Scholar 

  69. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM et al (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(5):1715–1744

    Article  PubMed  Google Scholar 

  70. Lunenfeld B, Mskhalaya G, Zitzmann M, Corona G, Arver S, Kalinchenko S et al (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. Aging Male 24(1):119–138

    Article  PubMed  Google Scholar 

  71. Sun K, Ren M, Liu D, Wang C, Yang C, Yan L (2014) Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies. Clin Nutr 33(4):596–602

    Article  PubMed  Google Scholar 

  72. Sun K, Liu J, Ning G (2012) Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS ONE 7(10):e47791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Lee G, Choi HY, Yang SJ (2015) Effects of dietary and physical activity interventions on metabolic syndrome: a meta-analysis. J Korean Acad Nurs 45(4):483–494

    Article  PubMed  Google Scholar 

  74. Castro VMF, Melo AC, Belo VS, Chaves VE (2017) Effect of allopurinol and uric acid normalization on serum lipids hyperuricemic subjects: a systematic review with meta-analysis. Clin Biochem 50(18):1289–1297

    Article  CAS  PubMed  Google Scholar 

  75. Kwon OY, Choi JY, Jang Y (2023) The effectiveness of ehealth interventions on lifestyle modification in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis. J Med Internet Res 25:e37487

    Article  PubMed  PubMed Central  Google Scholar 

  76. Sansone A, Reisman Y, Jannini EA (2022) Relationship between hyperuricemia with deposition and sexual dysfunction in males and females. J Endocrinol Investig 45(4):691–703

    Article  CAS  Google Scholar 

  77. Hasanain AFA, Mahdy RE, Mahran AMA, Safwat ASM, Mohamed AO, Abdel-Aal SM (2017) Erectile dysfunction in patients with nonalcoholic fatty liver disease. Arab J Gastroenterol 18(1):21–24

    Article  PubMed  Google Scholar 

  78. Wang XY, Huang W, Zhang Y (2018) Relation between hypertension and erectile dysfunction: a meta-analysisof cross-section studies. Int J Impot Res 30(3):141–146

    Article  PubMed  Google Scholar 

  79. Behr-Roussel D, Gorny D, Mevel K, Compagnie S, Kern P, Sivan V et al (2005) Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 288(1):R276–R283

    Article  CAS  PubMed  Google Scholar 

  80. Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L et al (2008) Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. J Androl 29(1):70–84

    Article  CAS  PubMed  Google Scholar 

  81. Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G et al (2009) Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6(1):285–293

  82. Corona G, Monami M, Boddi V, Rastrelli G, Melani C, Balzi D et al (2011) Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. J Sex Med 8(1):247–254

    Article  PubMed  Google Scholar 

  83. Farmakis IT, Pyrgidis N, Doundoulakis I, Mykoniatis I, Akrivos E, Giannakoulas G (2021) Effects of major antihypertensive drug classes on erectile function: a network meta-analysis. Cardiovasc Drugs Ther 36(5):903–914

    Article  PubMed  Google Scholar 

  84. Farmakis IT, Pyrgidis N, Doundoulakis I, Mykoniatis I, Akrivos E, Giannakoulas G (2022) Effects of major antihypertensive drug classes on erectile function: a network meta-analysis. Cardiovasc Drugs Ther 36(5):903–914

    Article  CAS  PubMed  Google Scholar 

  85. Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A et al (2017) High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 34(9):1185–1192

    Article  CAS  PubMed  Google Scholar 

  86. Corona G, Rastrelli G, Silverii A, Monami M, Sforza A, Forti G et al (2013) The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction. J Sex Med 10(4):1114–1123

    Article  PubMed  Google Scholar 

  87. Jin M, Yuan S, Wang B, Yi L, Wang C (2021) Association between prediabetes and erectile dysfunction: a meta-analysis. Front Endocrinol (Lausanne) 12:733434

    Article  PubMed  Google Scholar 

  88. Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E et al (2000) Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 29(3):524–531

    Article  CAS  PubMed  Google Scholar 

  89. Corona G, Bianchini S, Sforza A, Vignozzi L, Maggi M (2015) Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones (Athens) 14(4):569–578

    PubMed  Google Scholar 

  90. Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Jannini EA (2022) Sexual dysfunction in men and women with diabetes: a reflection of their complications? Curr Diabetes Rev 18(1):e030821192147

    Article  PubMed  Google Scholar 

  91. Li M, Ma Z, Zhang XL, Guo LQ, Yuan MZ (2020) Significance of blood lipid parameters as effective markers for arteriogenic erectile dysfunction. Andrology 8(5):1086–1094

    Article  CAS  PubMed  Google Scholar 

  92. Corona G, Cipriani S, Rastrelli G, Sforza A, Mannucci E, Maggi M (2016) High triglycerides predicts arteriogenic erectile dysfunction and major adverse cardiovascular events in subjects with sexual dysfunction. J Sex Med 13(9):1347–1358

    Article  PubMed  Google Scholar 

  93. Xu ZH, Xu HX, Jiang S, Xu QF, Ding K, Zhang DX et al (2021) Effect of high-density lipoprotein on penile erection: a cross-sectional study. Andrologia 53(5):e13979

    Article  CAS  PubMed  Google Scholar 

  94. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ (2000) High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 275(15):11278–11283

    Article  CAS  PubMed  Google Scholar 

  95. Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC (2000) Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol 73(3):231–236

    Article  CAS  PubMed  Google Scholar 

  96. Rämet ME, Rämet M, Lu Q, Nickerson M, Savolainen MJ, Malzone A et al (2003) High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J Am Coll Cardiol 41(12):2288–2297

    Article  PubMed  Google Scholar 

  97. Lotti F, Rastrelli G, Maseroli E, Cipriani S, Guaraldi F, Krausz C et al (2019) Impact of metabolically healthy obesity in patients with andrological problems. J Sex Med 16(6):821–832

    Article  PubMed  Google Scholar 

  98. Rastrelli G, Lotti F, Reisman Y, Sforza A, Maggi M, Corona G (2019) Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility. Expert Rev Endocrinol Metab 14(5):321–334

    Article  CAS  PubMed  Google Scholar 

  99. Molloy GJ, Stamatakis E, Randall G, Hamer M (2009) Marital status, gender and cardiovascular mortality: behavioural, psychological distress and metabolic explanations. Soc Sci Med 69(2):223–228

    Article  PubMed  PubMed Central  Google Scholar 

  100. Corona G, Rastrelli G, Monami M, Maseroli E, Jannini EA, Balercia G et al (2013) Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross-sectional and longitudinal analyses. Andrology 1(6):864–871

    Article  CAS  PubMed  Google Scholar 

  101. Maggi M, Corona G (2011) Love protects lover’s life. J Sex Med 8(4):931–935

    Article  PubMed  Google Scholar 

  102. Corona G, Bandini E, Fisher A, Elisa M, Boddi V, Balercia G et al (2010) Psychobiological correlates of women’s sexual interest as perceived by patients with erectile dysfunction. J Sex Med 7(6):2174–2183

    Article  PubMed  Google Scholar 

  103. Waite LJ (1995) Does marriage matter? Demography 32(4):483–507

    Article  CAS  PubMed  Google Scholar 

  104. Nizamani S, McFarlane RA, Knight-Agarwal CR, Somerset S (2022) Couples-based behaviour change interventions to reduce metabolic syndrome risk. A systematic review. Diabetes Metab Syndr 16(12):102662

    Article  CAS  PubMed  Google Scholar 

  105. Corona G, Pizzocaro A, Vena W, Rastrelli G, Semeraro F, Isidori AM et al (2021) Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis. Rev Endocr Metab Disord 22(2):275–296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Zhang J, Shi W, Zou M, Zeng Q, Feng Y, Luo Z et al (2023) Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis. J Endocrinol Invest 46(4):795–804. https://doi.org/10.1007/s40618-022-01945-w

    Article  CAS  PubMed  Google Scholar 

  107. Katz J, Yue S, Xue W, Gao H (2022) Increased odds ratio for erectile dysfunction in COVID-19 patients. J Endocrinol Investig 45(4):859–864

    Article  CAS  Google Scholar 

  108. Pizzol D, Shin JI, Trott M, Ilie PC, Ippoliti S, Carrie AM et al (2022) Social environmental impact of COVID-19 and erectile dysfunction: an explorative review. J Endocrinol Investig 45(3):483–487

    Article  CAS  Google Scholar 

  109. Paoli D, Pallotti F, Anzuini A, Bianchini S, Caponecchia L, Carraro A et al (2023) Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study. J Endocrinol Investig 46(1):89–101

    Article  CAS  Google Scholar 

  110. Corona G, Vena W, Pizzocaro A, Pallotti F, Paoli D, Rastrelli G et al (2022) Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. J Endocrinol Invest 45(12):2207–2219. https://doi.org/10.1007/s40618-022-01801-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Corona G, Baldi E, Isidori AM, Paoli D, Pallotti F, De Santis L et al (2020) SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità). J Endocrinol Investig 43(8):1153–1157

    Article  CAS  Google Scholar 

  112. Corona G (2022) Erectile dysfunction and premature ejaculation: a continuum movens supporting couple sexual dysfunction. J Endocrinol Investig 45(11):2029–2041

    Article  CAS  Google Scholar 

  113. Corona G, Rastrelli G, Bartfai G, Casanueva FF, Giwercman A, Antonio L et al (2021) Self-reported shorter than desired ejaculation latency and related distress-prevalence and clinical correlates: results from the European male ageing study. J Sex Med 18(5):908–919

    Article  PubMed  Google Scholar 

  114. Brody S, Weiss P (2015) Erectile dysfunction and premature ejaculation: interrelationships and psychosexual factors. J Sex Med 12(2):398–404

    Article  PubMed  Google Scholar 

  115. Li H, Xu W, Wang T, Wang S, Liu J, Jiang H (2022) Effect of weight loss on erectile function in men with overweight or obesity: a meta-analysis of randomised controlled trials. Andrologia 54(1):e14250

    Article  PubMed  Google Scholar 

  116. Gale EA (2005) The myth of the metabolic syndrome. Diabetologia 48(9):1679–1683

    Article  PubMed  Google Scholar 

  117. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9):2289–2304

    Article  PubMed  Google Scholar 

  118. Reaven GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51(6):931–938

    Article  CAS  PubMed  Google Scholar 

  119. Reaven G (2005) Counterpoint: just being alive is not good enough. Clin Chem 51(8):1354–1357

    Article  CAS  PubMed  Google Scholar 

  120. Grundy SM (2005) Point: the metabolic syndrome still lives. Clin Chem 51(8):1352–1354

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by GC and MM. The first draft of the manuscript was written by GC and MM, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to D. G. Corona.

Ethics declarations

Conflict of interest

None of the authors declared any conflict of interest.

Research involving human participants and/or animals

All the data provided were collected as part of the routine clinical procedure, according to our hospital’s approval protocol (L99-A08 292/2014) for the diagnostic workup for each patient referred to our unit for Sexual dysfunction.

Informed consent

For this type of the study no informed consent was required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corona, D.G., Vena, W., Pizzocaro, A. et al. Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study. J Endocrinol Invest 46, 2195–2211 (2023). https://doi.org/10.1007/s40618-023-02136-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-023-02136-x

Keywords

Navigation